References
- Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244(4902): 362–4
- Alter MJ. Epidemiology of hepatitis C in the West. Seminars in Liver Dis 1995; 15(1): 5–14
- Mitsui T, Iwano K, Masuko K, et al. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 1992; 16(5): 1109–14
- Akahane Y, Kojima M, Sugai Y, et al. Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med 1994; 120(9): 748–52
- Osmond DH, Padian NS, Sheppard HW, et al. Risk factors for hepatitis C virus sero-positivity in heterosexual couples. JAMA 1993; 269(3): 361–5
- Osmond DH, Charlebois E, Sheppard HW, et al. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis 1993; 167(1): 66–71
- Ohto H, Te razawa S, Sasaki N, et al. Transmission of hepatitis C virus from mothers to infants: the Vertical Transmission of Hepatitis C Virus Collaborative Study. N Engl J Med 1994: 330(11): 744–50
- Lin HH, Kao JH, Hsu HY, et al. Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus. J Infect Dis 1994; 169(3): 638–41
- Centers for Disease Control. Outbreak of hepatitis C associated with intravenous immunoglobulin administration—United States, October 1993-June 1994. MMWR 1994; 43(28): 505–9
- Simmonds P, Holmes EC, Cha XA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74(Pt ll): 2391–9
- McOmish F, Yap PL, Dow BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32(4): 884–92
- Lau JY, Davis GL, Kniffen J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993: 341 (8859): 1501–4 [Erratum, Lancet 1993; 342(8869): 504]
- Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in posttransfusion hepatitis: An analysis with first- and second-generation assays. N Engl J Med 1991; 325(19): 1325–9
- Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community- acquired hepatitis C in the United States. N Engl J Med 1992; 327(27): 1899–905
- Di Bisceglie AM, Goodman ZD, Ishak KG, et al. Long-term clinical and histopatho- logical follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14(6): 969–74
- Kiyosawa K, Akahane Y, Nagataa, et al. Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Am J Gastroenterol 1984; 79(10): 777–81
- DiBisceglie AM. Hepatitis C and hepatocellular carcinoma. Seminais in Liver Dis 1995; 15(l): 64–9
- Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion- associated non-A, non-B hepatitis. N Engl J Med 1992: 327(27): 1906–11
- Reichard O, Andersson J, Sch varra R, et al. Ribavirin treatment for chronic hepatitis C. Lancet 1991; 337(8749): 1058–61
- DiBisceglie AM, Shindo M, Fong TL, et al. A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology 1992; 16(3): 649–54
- Van Thiel DH, Friedlander L, Fagiuoli S, et al. Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol 1994; 20(3): 410–5
- Olynyk JK, Reddy RK, Di Bisceglie AM, et al. Hepatic iron concentration as a predictor of response to alfe interferon therapy in chronic hepatitis C. Gastroenterology 1995; 108(4): 1104–9
- Bacon BR, Rebholz AE, Fried M, et al. Beneficial effect of iron reduction therapy in patients with chronic hepatitis C who feiled to respond to interferon. Hepatology 1993: 18(10): 150A
- Van Thiel DH, Friedlander L, Malloy P, et al. Retreatment of hepatitis C interferon non- responders with larger doses of interferon with and without phlebotomy. Gastroenterology 1994; 106(5)A1002